arrow
E

Edmund K. Bartlett

Memorial Sloan Kettering Cancer Center
H指数:30
被引数:3,563

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience

侵袭性血管肌纤维母细胞瘤的自然病史和治疗结果:单一机构经验

2026-09-010
PRE
Retraction Note: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

撤稿说明:sFRP2在衰老微环境中驱动黑色素瘤转移和疗法抵抗

Nature
IF48.5
2025-10-290
OAAI
Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade

免疫学相关指标在一例对双重免疫检查点阻断敏感的CIC::DUX4融合阳性肉瘤中的表现

2025-03-250
OA
An open label phase IIa study evaluating the preliminary efficacy of intratumoural tigilanol tiglate (TT) in advanced and/or metastatic soft tissue sarcoma (STS)

一项开放标签的IIa期研究,评估肿瘤内注射tigilanol tiglate(TT)在晚期和/或转移性软组织肉瘤(STS)中的初步疗效。

2024-09-010
PRE
Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naive, advanced gastrointestinal stromal tumor (GIST)

循环肿瘤DNA(ctDNA)作为分子生物标志物在伊马替尼联合比尼替尼治疗初治、晚期胃肠道间质瘤(GIST)II期试验中的价值

2024-09-010
PRE